Cohance Lifesciences Limited has informed the Exchange about Schedule of meet
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cohance Lifesciences has informed the stock exchanges that its management will attend an investor roadshow in the US on June 6, 2025, organized as part of the 'Investec US Trip.' The roadshow is being held to showcase its US-based subsidiary, NJ Bio, Inc., based in Princeton, New Jersey, and will include both group sessions and one-on-one meetings. The company has clarified that no unpublished price-sensitive information (UPSI) will be shared during these interactions. The company is the renamed entity of Suven Pharmaceuticals Limited, and the schedule remains subject to change due to exigencies.
This is a routine disclosure and is unlikely to move the stock on its own, though it signals the company's investor outreach focus on its US subsidiary NJ Bio. Investors should watch for any follow-up announcements with material information shared during or after the roadshow.